Sionna Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SION research report →
About the company
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
- CEO
- Michael Cloonan
- IPO
- 2025
- Employees
- 41
- HQ
- Waltham, MA, US
Price Chart
- Market Cap
- $1.99B
- P/E
- -22.79
- P/S
- 0.00
- P/B
- 6.86
- EV/EBITDA
- -23.82
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -27.31%
- ROIC
- -33.35%
- Revenue
- $0 · 0.00%
- Net Income
- $-75,268,000 · -22.01%
- EPS
- $-1.88 · -34.29%
- Op Income
- $-88,982,000
- FCF YoY
- -26.24%
- 52W High
- $48.45
- 52W Low
- $16.38
- 50D MA
- $39.86
- 200D MA
- $38.04
- Beta
- 1.32
- Avg Volume
- 426.39K
Get TickerSpark's AI analysis on SION
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Thompson Peter A. | sell | 115,844 |
| Jun 30, 26 | ORBIMED ADVISORS LLC | sell | 115,844 |
| Jun 17, 26 | Stelzer Laurie | other | 17,340 |
| Jun 17, 26 | Viney Joanne L. | other | 17,340 |
| Jun 17, 26 | Thompson Peter A. | other | 17,340 |
| Jun 17, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 17,340 |
| Jun 17, 26 | Ruddy Marcella K. | other | 17,340 |
| Jun 17, 26 | Resnick Joshua | other | 17,340 |
| Jun 17, 26 | Fleming Harold Edward | other | 17,340 |
| Jun 17, 26 | Clancy Paul J | other | 17,340 |
Our SION coverage
Recent articles, reports, and earnings notes.
No research on SION yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SION report →Similar companies
Peers in the same neighborhood.